Webinar | Lincoln International and Latham & Watkins Discuss Capital Infusion Transactions

May 2020

On May 14, 2020, Chris Gregory, a Managing Director in Lincoln’s Valuations & Opinions Group and head of the Fairness & Solvency Opinion Practice is joined by Alex Stevenson, Managing Director and Co-Head of Lincoln International’s Special Situations Group, and Steve Stokdyk, former Co-Chair of Latham & Watkins Public Company Representation Practice, to discussed various aspects of capital infusion transactions. Topics discussed include:

The broad impact that the Coronavirus pandemic is having on company valuations and their leverage and liquidity
Current state of the private capital markets and options that are available to companies to address a funding gap through a third-party capital provider
Affiliate party capital infusions as an alternative to a third-party capital raise, whereby the incumbent private equity sponsor injects capital into its existing portfolio companies from the same fund or from a successor fund
Legal and corporate governance considerations for capital infusion transactions with a focus on cross-fund transactions
Overview of the fairness opinion analytical framework for a capital infusion transaction and valuation considerations for the current environment.

Complete the form below to begin webinar:

Summary

Lincoln International hosted a webcast with Latham & Watkins to discuss capital infusion transactions and implications of COVID-19.
Lincoln International has created a Playbook to support business leaders in documenting and articulating their COVID-19 response. To request a copy, click here.
Sign up to receive Lincoln's perspectives